A randomized, placebo-controlled, double-blind, multicenter study investigating basiliximab in combination with MMF, cyclosporin microemulsion and prednisone in the prevention of acute rejection in pediatric renal allograft recipients

Trial Profile

A randomized, placebo-controlled, double-blind, multicenter study investigating basiliximab in combination with MMF, cyclosporin microemulsion and prednisone in the prevention of acute rejection in pediatric renal allograft recipients

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2010

At a glance

  • Drugs Basiliximab (Primary) ; Ciclosporin; Mycophenolate mofetil
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 24 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top